newsfilter
← Latest News
PR Newswire·

UPNEEQ® Wins "Best in Innovation" Award from New Beauty

12th Annual Beauty Awards Selected from over 10,000 Entrants BRIDGEWATER, N.J. , April 6, 2022 /PRNewswire/ -- RVL Pharmaceuticals plc (NASDAQ:RVLP) announced today that its U.S. FDA approved acquired blepharoptosis (ptosis) drug UPNEEQ® (oxymetazo